Plantes à risques un ouvrage destiné aux pharmaciens, aux médecins, toxicologues et biologistes. Paris; Cachan: Éd Cannabis: approches thérapeutiques contemporaines, Cannabis en médecine un guide pratique des applications médicales du cannabis et du THC, 2008. ,
Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science, vol.258, issue.5090, pp.18-1992, 19469. ,
DOI : 10.1126/science.1470919
Aspects moléculaires, cellulaires et physiologiques des effets du cannabis The endocannabinoid signalling system Biochemical aspects, Académie des sciences (France) Endocannabinoid 2-Arachidonyl Glycerol Is a Full Agonist through Human Type 2 Cannabinoid Receptor: Antagonism by Anandamide, pp.1045-1050, 1997. ,
« Endocannabinoid Hedonic Hotspot for Sensory Pleasure: Anandamide in Nucleus Accumbens Shell Enhances Liking of a Sweet Reward, Neuropsychopharmacology, vol.9, pp.2267-2278, 2007. ,
THC: moderation during implantation, Nature Medicine, vol.10, issue.1, pp.19-20, 2004. ,
DOI : 10.1038/nm0104-19
« The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle, Fertility and Sterility, 2010. ,
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation, Proc. Natl. Acad. Sci, pp.14-8375, 1998. ,
DOI : 10.1073/pnas.95.14.8375
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors, Biochemical Pharmacology, vol.50, issue.1, pp.83-90 ,
DOI : 10.1016/0006-2952(95)00109-D
Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation, Neuroscience Letters, vol.297, issue.3, pp.175-178, 2001. ,
DOI : 10.1016/S0304-3940(00)01691-8
Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells, The FASEB Journal, pp.2171-2178 ,
« 2-arachidonoylglycerol: a novel inhibitor of androgenindependent prostate cancer cell invasion. », Cancer Res, pp.8826-8856 ,
Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages, Eur. J. Biochem, vol.264, issue.1, pp.258-267, 1999. ,
Further evidence for the existence of a specific process for the membrane transport of anandamide, Biochemical Journal, vol.380, issue.1, pp.265-272, 2004. ,
DOI : 10.1042/bj20031812
Design, Synthesis, and Biological Evaluation of New Inhibitors of the Endocannabinoid Uptake:?? Comparison with Effects on Fatty Acid Amidohydrolase, Journal of Medicinal Chemistry, vol.46, issue.8, pp.1512-1522, 2003. ,
DOI : 10.1021/jm0210818
The Activity of Anandamide at Vanilloid VR1 Receptors Requires Facilitated Transport across the Cell Membrane and Is Limited by Intracellular Metabolism, Journal of Biological Chemistry, vol.276, issue.16, pp.12856-63 ,
DOI : 10.1074/jbc.M008555200
et others, « An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors, Proc. Natl ,
Clarifying the Catalytic Roles of Conserved Residues in the Amidase Signature Family, Journal of Biological Chemistry, vol.275, issue.25, 2000. ,
DOI : 10.1074/jbc.M001607200
Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors, Biochemical Pharmacology, vol.57, issue.4, pp.417-440, 1999. ,
DOI : 10.1016/S0006-2952(98)00314-1
Segregation of two endocannabinoid-hydrolyzing enzymes into preand postsynaptic compartments in the rat hippocampus, cerebellum and amygdala », Eur J Neurosc, pp.441-58, 2004. ,
Oxidative metabolism of endocannabinoids, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), vol.66, issue.2-3, pp.211-220, 2002. ,
DOI : 10.1054/plef.2001.0359
Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase, J Med Chem, vol.20, pp.3709-3724 ,
A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus, British Journal of Pharmacology, vol.400, issue.1, pp.30-37, 2001. ,
DOI : 10.1038/sj.bjp.0704223
15-Lipoxygenase Metabolism of 2-Arachidonylglycerol. GENERATION OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR alpha AGONIST, Journal of Biological Chemistry, vol.277, issue.26, pp.23278-86 ,
DOI : 10.1074/jbc.M201084200
Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide, J. Pharmacol. Exp. Ther, vol.301, issue.3, pp.900-907, 2002. ,
Prostaglandin Ethanolamides (Prostamides): In Vitro Pharmacology and Metabolism, Journal of Pharmacology and Experimental Therapeutics, vol.309, issue.2, pp.745-57 ,
DOI : 10.1124/jpet.103.061705
The Effect of Cannabidiol on Mouse Hepatic Microsomal Cytochrome P450-Dependent Anandamide Metabolism, Biochemical and Biophysical Research Communications, vol.197, issue.2, pp.740-746, 1993. ,
DOI : 10.1006/bbrc.1993.2541
Microsomal cytochrome P450-mediated liver and brain anandamide metabolism, Microsomal cytochrome P450- mediated liver and brain anandamide metabolism, pp.677-686, 1995. ,
DOI : 10.1016/0006-2952(95)00177-2
« A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae) », Botany, pp.101-2014 ,
Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid, Invest Ophthalmol Vis Sci, pp.3216-3238 ,
Cannabinoid activation of PPAR??; a novel neuroprotective mechanism, British Journal of Pharmacology, vol.400, issue.5, pp.734-743 ,
DOI : 10.1038/sj.bjp.0707478
CAS 199875-69-9) (Inchi key MVVPIAAVGAWJNQ-DOFZRALJSA-N) || Cayman Chemical | Supplier ». [En ligne]. Disponible sur: https://www.caymanchem.com, pp.27-2015 ,
The biosynthesis of N-arachidonoyl dopamine (NADA), a putative endocannabinoid and endovanilloid, via conjugation of arachidonic acid with dopamine, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.81, pp.291-301, 2009. ,
TRPV1 and CB1 receptor-mediated effects of the endovanilloid/endocannabinoid N-arachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat, European Journal of Neuroscience, vol.59, issue.1, pp.175-84, 2004. ,
DOI : 10.1016/0306-4522(94)90218-6
« Vascular effects of delta 9- tetrahydrocannabinol (THC), anandamide and N -arachidonoyldopamine (NADA) in the rat isolated aorta, pp.507-211, 2005. ,
« N-Arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors, pp.32-298, 2007. ,
« Enhancement of spontaneous and heat-evoked activity in spinal nociceptive neurons by the endovanilloid, NADA), vol.95, pp.1207-1212, 2006. ,
Arachidonoyl ethanolamine (Virodhamine or OAE) Type.jpg -Wikimedia Commons ». [En ligne] Disponible sur: https://commons.wikimedia.org/wiki/File:Endocannabinoid_Structure_-_O [47] Porter AC et al, « Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor, J Pharmacol Exp Ther, pp.1020-1024 ,
Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells, British Journal of Pharmacology, vol.23, issue.7, pp.1041-1048 ,
DOI : 10.1038/sj.bjp.0707320
The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55, Journal of Neuroimmune Pharmacology, vol.284, issue.18, p.2012 ,
DOI : 10.1007/s11481-012-9351-6
« Lysophosphatidylinositol signalling: new wine from an old bottle, Biochim Biophys Acta, pp.694-705 ,
A novel biological role for the phospholipid lysophosphatidylinositol in nociceptive sensitization via activation of diverse Gprotein signalling pathways in sensory nerves in vivo, Pain, pp.2801-2813 ,
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish, Journal of the American Chemical Society, vol.86, issue.8, pp.1646-1647, 1964. ,
DOI : 10.1021/ja01062a046
Disponible sur: http://toxnet.nlm.nih.gov/cgi- bin/sis/search2/f?, Consulté le, pp.18-2014 ,
Hbarton3/Cannabidiol Effects on Epilepsy -Wikipedia, the free encyclopedia ». [En ligne]. Disponible sur: https://en.wikipedia.org/wiki, pp.27-2015 ,
The orphan receptor GPR55 is a novel cannabinoid receptor, British Journal of Pharmacology, vol.96, issue.69, pp.1092-1101 ,
DOI : 10.1038/sj.bjp.0707460
Agonistic Properties of Cannabidiol at 5-HT1a Receptors, Neurochemical Research, vol.54, issue.2, pp.1037-1043 ,
DOI : 10.1007/s11064-005-6978-1
Eberhard Schlicker, « Cannabidiol is an allosteric modulator at mu-and delta-opioid receptors », Archives of Pharmacology, pp.18-2006 ,
is-cannabigerol-cbg-the-ultimate- cannabinoid, Consulté le, pp.27-2014, 2013. ,
Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action, British Journal of Pharmacology, vol.159, issue.1 ,
DOI : 10.1111/j.1476-5381.2010.01063.x
Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice », Br J Pharmacol, pp.1444-1460 ,
The effect of cannabichromene on adult neural stem/progenitor cells, Neurochemistry International, vol.63, issue.5, pp.432-437 ,
DOI : 10.1016/j.neuint.2013.08.002
the free encyclopedia ». [En ligne] Disponible sur: https://en.wikipedia.org/wiki, Tetrahydrocannabivarin.Consulté, vol.le, pp.27-2015 ,
Aminoalkylindole Analogs: Cannabimimetic Activity of a Class of Compounds Structurally Distinct from ?9, Tetrahydrocannabinol » Journal of Pharmacology and Experimental Therapeutics, pp.1118-1126, 1992. ,
212-2-2D-skeletal.svg -Wikimedia Commons ». [En ligne] Disponible sur: https://commons.wikimedia.org/wiki/File:WIN_55,212-2-2D-skeletal, pp.27-2015 ,
212-2 -BML-CR105 -Enzo Life Sciences ». [En ligne] Disponible sur, www.enzolifesciences.com/BML-CR105/win-55-212-2/. [Consulté le, pp.22-2014 ,
CAS 209414-07-3) || Cayman Chemical | Supplier ». [En ligne] Disponible sur: https://www.caymanchem.com/app/template/Product.vm/catalog, Consulté le, pp.22-2014, 10900. ,
A novel probe for the cannabinoid receptor, Journal of Medicinal Chemistry, vol.35, issue.11, pp.2065-2069, 1992. ,
DOI : 10.1021/jm00089a018
HU-210 chemical structure.png -Wikimedia Commons ». [En ligne] Disponible sur: https://commons.wikimedia.org/wiki/File:HU-210_chemical_structure.png, Consulté le, pp.27-2015 ,
The Total Synthesis of Cannabinoids, Total Synthesis of Natural Products, pp.185-262, 1981. ,
DOI : 10.1002/9780470129678.ch2
940 -Wikipedia, the free encyclopedia ». [En ligne] Disponible sur: https://en.wikipedia.org/wiki, pp.27-2015 ,
En ligne] Disponible sur: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0409d82-a61e-4b9e-8717- ced299ccedb2, Consulté le, pp.30-2014 ,
Clinical Experience with Levonantradol Hydrochloride in the Prevention of Cancer Chemotherapy-Induced Nausea and Vomiting, The Journal of Clinical Pharmacology, vol.300, issue.S1, pp.86-89 ,
DOI : 10.1002/j.1552-4604.1981.tb02580.x
Antiemetic Effect of Intramuscular Levonantradol in Patients Receiving Anticancer Chemotherapy, The Journal of Clinical Pharmacology, vol.21, issue.S1, pp.43-50 ,
DOI : 10.1002/j.1552-4604.1981.tb02572.x
Nabilone Capsules) Drug Information: Description, User Reviews, Drug Side Effects, Interactions -Prescribing Information at RxList ». [En ligne]. Disponible sur, pp.2-2015 ,
En ligne] Disponible sur: http://www.alchimiaweb.com/blogfr/cannabismedicaments-cesamet-marinol-sativex, Consulté le, pp.2-2015 ,
the free encyclopedia ». [En ligne] Disponible sur: https://en.wikipedia.org/wiki, pp.27-2015 ,
Generic Acomplia) -Uses, Dosage and Side effects | Medical Cheat Sheets ». [En ligne] Disponible sur: http://medicalcheatsheets.blogspot.fr/2011/03/rimonabant-tablets-generic-acomplia.html, Consulté le, pp.27-2015 ,
En ligne] Disponible sur, pp.20-2014 ,
En ligne] Disponible sur, pp.22-2014 ,
The neurobiology and evolution of cannabinoid signalling, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.356, issue.1407, pp.381-408 ,
DOI : 10.1098/rstb.2000.0787
The Endocannabinoid System as an Emerging Target of Pharmacotherapy, Pharmacological Reviews, vol.58, issue.3, pp.389-462 ,
DOI : 10.1124/pr.58.3.2
Pain, Peppers, and Prostaglandins | Article Library || Cayman Chemical | Supplier ». [En ligne]. Disponible sur: https, pp.22-2015 ,
« Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal betacells , isolated pancreatic islets and mice », Br J Pharmacol, pp.978-990 ,
Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (Review), Oncology Reports, vol.17, issue.4, pp.813-816, 2007. ,
DOI : 10.3892/or.17.4.813
Control of the cell survival/death decision by cannabinoids, Journal of Molecular Medicine, vol.78, issue.11, pp.613-625, 2001. ,
DOI : 10.1007/s001090000177
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol, Phytomedicine, vol.21, issue.5, 2013. ,
DOI : 10.1016/j.phymed.2013.11.006
Expression and function of fatty acid amide hydrolase in prostate cancer, International Journal of Cancer, vol.86, issue.Part 1, pp.1318-1326, 2008. ,
DOI : 10.1002/ijc.23674
[En ligne] Disponible sur: http://sante-medecine.commentcamarche.net/contents/132-cancer-du-sein- symptomes-et-traitement, Consulté le, pp.26-2014 ,
« Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis, Proc. Natl. Acad. Sci. U. S. A, vol.100, issue.23, pp.13543-13548, 2003. ,
Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells, Molecular Cancer Therapeutics, vol.6, issue.11, pp.2921-2927, 2007. ,
DOI : 10.1158/1535-7163.MCT-07-0371
En ligne] Disponible sur: http://santemedecine .commentcamarche.net/faq/13389-gliome-definition, Consulté le, pp.27-2014 ,
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma, Molecular Cancer Therapeutics, vol.10, issue.1, pp.90-103 ,
DOI : 10.1158/1535-7163.MCT-10-0688
En ligne] Disponible sur, pp.25-2014 ,
En ligne] Disponible sur, pp.3-2015 ,
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb, Trends in Pharmacological Sciences, vol.30, issue.10, pp.512-539 ,
DOI : 10.1016/j.tips.2009.07.006
Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression, Proceedings of the National Academy of Sciences, vol.103, issue.20 ,
DOI : 10.1073/pnas.0511232103
WITHDRAWN: Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures, Seizure, pp.344-52 ,
DOI : 10.1016/j.seizure.2010.12.002
« Cannabidiol interferes with the effects of delta 9 -tetrahydrocannabinol in man », Eur J Pharmacol, pp.172-179 ,
En ligne] Disponible sur: http://sensiseeds.com/fr/blog/cannabis-et-glaucome, Consulté le, pp.3-2015 ,
En ligne] Disponible sur: http://www.leglaucome.fr/sinformer/quest-ce-que-le-glaucome, Consulté le, pp.3-2015 ,
En ligne] Disponible sur, pp.5-2015 ,
« Delta9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1, 1998. ,
Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation, J Immunol, pp.2373-82 ,
Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation, J Immunol ,
A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells, International Immunopharmacology, vol.8, issue.5, pp.732-772 ,
DOI : 10.1016/j.intimp.2008.01.018
Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures, Journal of Neuroscience Research, vol.256, issue.6, pp.829-865 ,
DOI : 10.1002/jnr.10165
Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis, Journal of Neuroimmunology, vol.193, issue.1-2, pp.120-129 ,
DOI : 10.1016/j.jneuroim.2007.10.024
« Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection, J Immunol, pp.6461-6467 ,
« Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. -PubMed -NCBI, Immunopharmacology, pp.179-85 ,
« Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells, Glia, pp.58-69 ,
Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid, Rheumatology International, vol.100, issue.7, pp.631-636 ,
DOI : 10.1007/s00296-007-0489-0
a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells, pp.1448-57 ,
« Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and, Mol Pharmacol, issue.2, pp.101-112 ,
Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis, Journal of Neurochemistry, vol.118, issue.6, pp.1327-1366 ,
DOI : 10.1111/j.1471-4159.2004.02979.x
Progesterone Up-Regulates Anandamide Hydrolase in Human Lymphocytes: Role of Cytokines and Implications for Fertility, The Journal of Immunology, vol.166, issue.12, pp.7183-7192 ,
DOI : 10.4049/jimmunol.166.12.7183
Cannabinoids as novel anti-inflammatory drugs, Future Medicinal Chemistry, vol.1, issue.7, pp.1333-1349 ,
DOI : 10.4155/fmc.09.93
Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes, Molecular Immunology, vol.43, issue.14, pp.2169-79 ,
DOI : 10.1016/j.molimm.2006.01.005
T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis, Glia, vol.31, issue.2, p.2001 ,
DOI : 10.1002/glia.1111
« CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies », Br J Pharmacol, pp.216-241 ,
R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: Partial involvement of the CB2 receptor, Biochemical Pharmacology, vol.72, issue.12, pp.1697-706 ,
DOI : 10.1016/j.bcp.2006.08.018
« Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta- stimulated human astrocytes, Glia, pp.211-220 ,
The CB2 Cannabinoid Receptor Controls Myeloid Progenitor Trafficking: INVOLVEMENT IN THE PATHOGENESIS OF AN ANIMAL MODEL OF MULTIPLE SCLEROSIS, Journal of Biological Chemistry, vol.283, issue.19, pp.13320-13329 ,
DOI : 10.1074/jbc.M707960200
« Current concepts in the pathogenesis of early rheumatoid arthritis, Best Pract Res Clin Rheumatol, pp.37-48 ,
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis, Proceedings of the National Academy of Sciences, vol.97, issue.17, pp.9561-9566 ,
DOI : 10.1073/pnas.160105897
« Suppression of human monocyte interleukin-1beta production by ajulemic acid, a nonpsychoactive cannabinoid, Biochem Pharmacol, pp.649-55 ,
Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells, Journal of Cellular Physiology, vol.65, issue.3, pp.714-734 ,
DOI : 10.1002/jcp.21263
et others, « ?8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors, Br. J. Pharmacol, vol.165, issue.8, pp.2450-2461, 2012. ,
Disponible sur: http://www.inserm.fr/thematiques/neurosciences-sciences-cognitives-neurologiepsychiatrie/dossiers-d-information/maladie-de-parkinson, Consulté le, pp.4-2014 ,
Non-motor symptoms of Parkinson's disease: diagnosis and management, The Lancet Neurology, vol.5, issue.3, pp.235-245, 2006. ,
DOI : 10.1016/S1474-4422(06)70373-8
Parkinson: chiffres clés et prevalence Atlas neurologique -OMS, 2004. ,
« Prevalence and incidence of Parkinson's disease in Europe, Eur. Neuropsychopharmacol, vol.15, issue.4, pp.473-490, 2005. ,
UFR Pharmacie-Institut des maladies neurodégénératives, Cours de 2ème année de pharmacie, Anatomie-Physiologie, pp.2011-2010 ,
Stanzione, et others, « High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients, Ann. Neurol, vol.57, issue.5, pp.777-779, 2005. ,
-THCV in animal models of Parkinson's disease, British Journal of Pharmacology, vol.146, issue.1074, pp.1495-1506, 2011. ,
DOI : 10.1111/j.1476-5381.2011.01278.x
URL : https://hal.archives-ouvertes.fr/in2p3-00121621
S]GTP??S binding in mouse brain cerebellum and piriform cortex membranes, British Journal of Pharmacology, vol.77, issue.6, pp.1349-1358, 2008. ,
DOI : 10.1038/bjp.2008.190
-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum, British Journal of Pharmacology, vol.25, issue.Suppl. 1, pp.204-215, 2008. ,
DOI : 10.1038/bjp.2008.57
URL : https://hal.archives-ouvertes.fr/hal-00018610
« The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: ?9-tetrahydrocannabinol, cannabidiol and ?9-tetrahydrocannabivarin, Br. J. Pharmacol, vol.153, issue.2, 2008. ,
Marijuana chemistry: genetics, processing & potency, 1990. ,
Marijuana and the cannabinoids, 2007. ,
DOI : 10.1007/978-1-59259-947-9
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb, Trends in Pharmacological Sciences, vol.30, issue.10, pp.515-527, 2009. ,
DOI : 10.1016/j.tips.2009.07.006
« An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatments, Curr. Med. Chem, vol.13, pp.30-3705, 2006. ,
The endocannabinoid system as a target for the treatment of motor dysfunction, British Journal of Pharmacology, vol.276, issue.1074, pp.1029-1040, 2009. ,
DOI : 10.1111/j.1476-5381.2008.00088.x
Sañudo-Peña, « Pain modulation by release of the endogenous cannabinoid anandamide, Proc. Natl. Acad. Sci, pp.12198-12203, 1999. ,
Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors, Pain, vol.75, issue.1, pp.111-119, 1998. ,
DOI : 10.1016/S0304-3959(97)00213-3
« Potential role of cannabinoids in Parkinson's disease », Drugs Aging, vol.16, issue.6, pp.391-395, 2000. ,
Monographie de produit pour Marinol, 2010. ,
Human Cannabinoid Pharmacokinetics, Human cannabinoid pharmacokinetics, pp.1770-1804, 2007. ,
DOI : 10.1002/cbdv.200790152
Absorption, Distribution, and Biotransformation of the Cannabinoids, Marihuana and medicine, pp.91-103, 1999. ,
DOI : 10.1007/978-1-59259-710-9_10
« Plasma protein binding of 7-hydroxy-1-tetrahydrocannabinol: an active 1-tetrahydrocannabinol metabolite, J Pharm Pharmacol, pp.453-460 ,
The pharmacokinetics of THC in fat and brain: resulting functional responses to marihuana smoking, Human Psychopharmacology: Clinical and Experimental, vol.46, issue.3, pp.247-255, 2001. ,
DOI : 10.1002/hup.258
-Tetrahydrocannabinol and Related Cannabinoids in Man, The Journal of Clinical Pharmacology, vol.32, issue.S1, pp.178-189, 1981. ,
DOI : 10.1002/j.1552-4604.1981.tb02594.x
URL : https://hal.archives-ouvertes.fr/hal-00480375
En ligne] Disponible sur: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0409d82-a61e-4b9e-8717- ced299ccedb2, Consulté le, pp.20-2014 ,
Handook of pharmaceutical excipients, 2009. ,
Pharmacie Galénique : formulation et technologie pharmaceutique. 2ème édition, 2ème édition ,
Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients with Dyslipidemia, New England Journal of Medicine, vol.353, issue.20, pp.20-2121, 2005. ,
DOI : 10.1056/NEJMoa044537
Agence nationale de sécurité du médicament et des produits de santé ». [En ligne]. Disponible sur: http://ansm.sante, Consulté le, pp.29-2014 ,
suspension d'AMM annoncée, p.897, 2008. ,
Astrup, « Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials », The Lancet, pp.9600-1706, 2007. ,
« De la consommation au sevrage (cannabis, cocaïne, amphétamines, héroïne), en milieu libre ou en milieu carcéral : prises en charge et rôle du pharmacien d'officine, 2014. ,
Disponible sur: https://www.alchimiaweb.com/blogfr/projet-loilegalisation-cannabis-france, Consulté le, pp.27-2015 ,
En ligne] Disponible sur: http://www.ofdt.fr/produits-et-addictions, Consulté le, pp.24-2015 ,
le cannabis est une drogue mortelle Campagne d'information et de sensibilisation des jeunes / Publications presse / Espace presse -Sécurité routière | Tous responsables ». [En ligne] Disponible sur: http://www.securiteroutiere.gouv.fr/medias/espace-presse/publications-presse/sur-la-route-le-cannabis-estune-drogue-mortelle-campagne-d-information-et-de-sensibilisation-des-jeunes, pp.22-2015 ,